| Critical Care | |
| Post-extubation oxygenation strategies in acute respiratory failure: a systematic review and network meta-analysis | |
| Yu Onodera1  Takuya Mayumi2  Hiromu Okano3  Chihiro Narita4  Hideto Yasuda5  Nobuaki Shime6  Masaki Nakane7  | |
| [1] Department of Anesthesiology, Yamagata University Faculty of Medicine;Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University;Department of Critical and Emergency Medicine, National Hospital Organization Yokohama Medical Center;Department of Emergency Medicine, Shizuoka General Hospital;Department of Emergency and Critical Care Medicine, Jichi Medical University Saitama Medical Center;Department of Emergency and Critical Care Medicine, Postgraduate School of Medical Science, Hiroshima University Hospital;Department of Emergency and Critical Care Medicine, Yamagata University Hospital; | |
| 关键词: Post-extubation; Conventional oxygen therapy; Noninvasive ventilation; High-flow nasal cannula; Systematic review; Meta-analysis; | |
| DOI : 10.1186/s13054-021-03550-4 | |
| 来源: DOAJ | |
【 摘 要 】
Abstract Background High-flow nasal cannula oxygenation (HFNC) and noninvasive positive-pressure ventilation (NPPV) possibly decrease tracheal reintubation rates better than conventional oxygen therapy (COT); however, few large-scale studies have compared HFNC and NPPV. We conducted a network meta-analysis (NMA) to compare the effectiveness of three post-extubation respiratory support devices (HFNC, NPPV, and COT) in reducing the mortality and reintubation risk. Methods The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, and Ichushi databases were searched. COT, NPPV, and HFNC use were assessed in patients who were aged ≥ 16 years, underwent invasive mechanical ventilation for > 12 h for acute respiratory failure, and were scheduled for extubation after spontaneous breathing trials. The GRADE Working Group Approach was performed using a frequentist-based approach with multivariate random-effect meta-analysis. Short-term mortality and reintubation and post-extubation respiratory failure rates were compared. Results After evaluating 4631 records, 15 studies and 2600 patients were included. The main cause of acute hypoxic respiratory failure was pneumonia. Although NPPV/HFNC use did not significantly lower the mortality risk (relative risk [95% confidence interval] 0.75 [0.53–1.06] and 0.92 [0.67–1.27]; low and moderate certainty, respectively), HFNC use significantly lowered the reintubation risk (0.54 [0.32–0.89]; high certainty) compared to COT use. The associations of mortality with NPPV and HFNC use with respect to either outcome did not differ significantly (short-term mortality and reintubation, relative risk [95% confidence interval] 0.81 [0.61–1.08] and 1.02 [0.53–1.97]; moderate and very low certainty, respectively). Conclusion NPPV or HFNC use may not reduce the risk of short-term mortality; however, they may reduce the risk of endotracheal reintubation. Trial registration number and date of registration PROSPERO (registration number: CRD42020139112, 01/21/2020).
【 授权许可】
Unknown